Expectations re. future EUPATI e-learning platform
Involving patients in research can hugely benefit the medicines development process: by bringing in their priorities and perspectives, patients can contribute to developing better treatments for them and others. Greater patient involvement in R&D will boost the efficacy and safety of new treatments and increase public support for medical research.
EUPATI works to develop an e-learning platform on medicines development. To get the best background for that the organisation has launched an online survey on expectations to such a platform to understand the motivation, as well as efforts and resources that patients and patient representatives (and other stakeholders) would be willing to invest in this future EUPATI e-learning platform.
The online survey falls under an EIT Health funded project called EUPATI Reload with European Patients' Forum, Bayer and Biopeople/University of Copenhagen as partners.
Should you besides from answering the questionnaire have any questions, ideas or suggestions, please drop a line to email@example.com!
EUPATI Reload and EUPATI Team thank you for your collaboration
Please find the link to the online survey here.